Form4insider filings, from the source

SEC Form 4 · accession 0000904454-18-000522

Bionano Genomics, Inc. · BNGO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Jesse I Treu
10% Owner
James C Blair
10% Owner
Brian H Dovey
10% Owner
Brian K Halak
10% Owner
Period of report
Aug 23, 2018
Accepted (ET)
Aug 27, 2018 · 5:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001411690

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Aug 23, 2018C591,184—A591,184D
Common StockF3,F2Aug 23, 2018C337,694$4.59A929,878D
Common StockF4,F2Aug 23, 2018P15,000$6.125A943,878D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series B Preferred StockF2,F1—Aug 23, 2018C6,810,098D——Common Stock159,1150D
Series B-1 Preferred StockF2,F1—Aug 23, 2018C2,986,762D——Common Stock69,7840D
Series C Preferred StockF2,F1—Aug 23, 2018C5,426,808D——Common Stock126,7940D
Series D Preferred StockF2,F1—Aug 23, 2018C6,396,105D——Common Stock149,4410D
Series D-1 Preferred StockF2,F1—Aug 23, 2018C3,682,919D——Common Stock86,0500D
Convertible Promissory NoteF3,F2$4.59Aug 23, 2018C—D——Common Stock337,6940D
Warrants to Purchase Common StockF4,F2$6.125Aug 23, 2018P15,000ASep 20, 2018Sep 20, 2023Common Stock15,00015,000D

Explanation of responses